The aim of this proposal is to determine the metabolic regulation, function, and significance of the de novo pathway for PAF biosynthesis in the normal kidney and in renal-induced hypertension and chemically-induced renal necrosis. Specific projects center on the following topics: (a) purification of the acetyltransferase and DTT-insensitive cholinephosphotransferase in the de novo PAF pathway for studies of their properties, development of antibodies against the enzymes, and long-range plans for molecular biology experiments, (b) regulatory controls (enzyme synthesis vs. allosteric factors) that will examine the influence of activators such as hormones, phosphorylation-dephosphorylation of proteins, """"""""cross-talk"""""""" between intermediates of the remodeling and de novo routes, metal ions, and other determinants and inhibitors (both physiological and pharmacological agents) on the de novo synthesis of PAF and its subsequent metabolic fate; (c) catabolism of alkylacetylglycerols (the immediate precursor of de novo PAF) and their retroconversion to alkylacylglycerols and alkylacylglycerophosphocholines (PAF precursor in the remodeling route); (d) topography of enzymes, precursors, and products among membrane systems; and (e) metabolism of an acetylated form of an ether-linked triglyceride analog. Animal models for investigating the enzymes of the de novo pathway of PAF synthesis in kidney diseases will include renal medullary necrosis induced by bromoethylamine hydrobromide and renal hypertension in the 1-clip 1-kidney rat model and spontaneous hypertensive [SHR] rats. Methodology involves enzymological procedures, cell culture, and lipid/protein chromatographic and chemical techniques. We anticipate the results of our studies will lead to a full understanding of the metabolism, regulatory controls, and the underlying biochemical mechanisms that explain how the de novo pathway of PAF biosynthesis is involved in both physiological and pathological functions of the kidney. Another expectation will be the gain of new knowledge about the biochemistry of the alkylacetylglycerols (and the long-chain acyl analog) and alkylglycerols formed in the de novo route of PAF synthesis, since the alkylacetylglycerols (and alkylacylglycerols) are an important type of """"""""diglyceride analog"""""""" with biological activities involved in the modulation of protein kinase C and cellular differentiation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL035495-07
Application #
3349428
Study Section
Biochemistry Study Section (BIO)
Project Start
1985-12-01
Project End
1994-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Oak Ridge Associated Universities
Department
Type
DUNS #
City
Oak Ridge
State
TN
Country
United States
Zip Code
37831
Snyder, F (1995) Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta 1254:231-49
Lee, T C; Fitzgerald, V; Chatterjee, R et al. (1994) Differentiation induced increase of platelet-activating factor acetylhydrolase in HL-60 cells. J Lipid Mediat Cell Signal 9:267-83
Blank, M L; Smith, Z L; Cress, E A et al. (1994) Molecular species of ethanolamine plasmalogens and transacylase activity in rat tissues are altered by fish oil diets. Biochim Biophys Acta 1214:295-302
Snyder, F (1994) Metabolic processing of PAF. Clin Rev Allergy 12:309-27
Blank, M L; Fitzgerald, V; Lee, T C et al. (1993) Evidence for biosynthesis of plasmenylcholine from plasmenylethanolamine in HL-60 cells. Biochim Biophys Acta 1166:309-12
Blank, M L; Smith, Z L; Snyder, F (1993) Arachidonate-containing triacylglycerols: biosynthesis and a lipolytic mechanism for the release and transfer of arachidonate to phospholipids in HL-60 cells. Biochim Biophys Acta 1170:275-82
Lee, T C; Uemura, Y; Snyder, F (1992) A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acyl analogs of platelet-activating factor (PAF) with PAF as the acetate donor in HL-60 cells. J Biol Chem 267:19992-20001
Snyder, F (1989) Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids. Proc Soc Exp Biol Med 190:125-35
Qian, C G; Lee, T C; Snyder, F (1989) Metabolism of platelet activating factor (PAF) and related ether lipids by neonatal rat myocytes. J Lipid Mediat 1:113-23
Kawasaki, T; Snyder, F (1988) Synthesis of a novel acetylated neutral lipid related to platelet-activating factor by acyl-CoA:1-O-alkyl-2-acetyl-sn-glycerol acyltransferase in HL-60 cells. J Biol Chem 263:2593-6

Showing the most recent 10 out of 16 publications